Organizations Call on GSK to Join UNITAID Patent PoolSeptember 9, 2009 A letter from 15 organizations -- including the Stop Aids Campaign, Medicines Sans Frontiers, UNICEF and Christian Aid -- calls on drug company GlaxoSmithKline to join UNITAID's patent pool, "which aims to improve access to drugs for HIV/AIDS and other diseases in poor countries," the Guardian writes. Andrew Witty, the chief executive of GSK, has cut prices of drugs in developing countries and "launched a patent pool of his own, with more than 800 compounds and molecules that might be useful to researchers into neglected diseases," but he says AIDS is not neglected (Boseley, 9/6). Back to other news for September 2009
This article was provided by Henry J. Kaiser Family Foundation. It is a part of the publication Kaiser Daily Global Health Policy Report.
|